168 related articles for article (PubMed ID: 38471712)
21. Expression of interferon-γ, interferon-α and related genes in individuals with Down syndrome and periodontitis.
Tanaka MH; Giro EM; Cavalcante LB; Pires JR; Apponi LH; Valentini SR; Spolidório DM; Capela MV; Rossa C; Scarel-Caminaga RM
Cytokine; 2012 Dec; 60(3):875-81. PubMed ID: 22995210
[TBL] [Abstract][Full Text] [Related]
22. Tumor cell-intrinsic SETD2 inactivation sensitizes cancer cells to immune checkpoint blockade through the NR2F1-STAT1 pathway.
Zheng X; Luo Y; Xiong Y; Liu X; Zeng C; Lu X; Wang X; Cheng Y; Wang S; Lan H; Wang K; Weng Z; Bi W; Gan X; Jia X; Wang L; Wang Y
J Immunother Cancer; 2023 Dec; 11(12):. PubMed ID: 38056895
[TBL] [Abstract][Full Text] [Related]
23. LPCAT3 Inhibitors Remodel the Polyunsaturated Phospholipid Content of Human Cells and Protect from Ferroptosis.
Reed A; Ichu TA; Milosevich N; Melillo B; Schafroth MA; Otsuka Y; Scampavia L; Spicer TP; Cravatt BF
ACS Chem Biol; 2022 Jun; 17(6):1607-1618. PubMed ID: 35658397
[TBL] [Abstract][Full Text] [Related]
24. IL-27 mediates HLA class I up-regulation, which can be inhibited by the IL-6 pathway, in HLA-deficient Small Cell Lung Cancer cells.
Carbotti G; Nikpoor AR; Vacca P; Gangemi R; Giordano C; Campelli F; Ferrini S; Fabbi M
J Exp Clin Cancer Res; 2017 Oct; 36(1):140. PubMed ID: 29020964
[TBL] [Abstract][Full Text] [Related]
25. Hydrazide/Metal/Indocyanine Green Coordinated Nanoplatform for Potentiating Reciprocal Ferroptosis and Immunity against Melanoma.
Hou G; Qian J; Wang Y; Xu W; Guo M; Li Z; Wang J; Suo A
ACS Appl Mater Interfaces; 2023 Aug; 15(31):37143-37156. PubMed ID: 37498789
[TBL] [Abstract][Full Text] [Related]
26. IFN-γ Induces IL-15
Kim TS; Rha MS; Shin EC
J Immunol; 2022 Jan; 208(2):338-346. PubMed ID: 34893528
[TBL] [Abstract][Full Text] [Related]
27. CD8
Wang W; Green M; Choi JE; Gijón M; Kennedy PD; Johnson JK; Liao P; Lang X; Kryczek I; Sell A; Xia H; Zhou J; Li G; Li J; Li W; Wei S; Vatan L; Zhang H; Szeliga W; Gu W; Liu R; Lawrence TS; Lamb C; Tanno Y; Cieslik M; Stone E; Georgiou G; Chan TA; Chinnaiyan A; Zou W
Nature; 2019 May; 569(7755):270-274. PubMed ID: 31043744
[TBL] [Abstract][Full Text] [Related]
28. Closed system RT-qPCR as a potential companion diagnostic test for immunotherapy outcome in metastatic melanoma.
Gupta S; McCann L; Chan YGY; Lai EW; Wei W; Wong PF; Smithy JW; Weidler J; Rhees B; Bates M; Kluger HM; Rimm DL
J Immunother Cancer; 2019 Sep; 7(1):254. PubMed ID: 31533832
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of interferon-gamma-stimulated melanoma progression by targeting neuronal nitric oxide synthase (nNOS).
Tong S; Cinelli MA; El-Sayed NS; Huang H; Patel A; Silverman RB; Yang S
Sci Rep; 2022 Feb; 12(1):1701. PubMed ID: 35105915
[TBL] [Abstract][Full Text] [Related]
30. Interferon-γ induces salivary gland epithelial cell ferroptosis in Sjogren's syndrome via JAK/STAT1-mediated inhibition of system Xc
Cao T; Zhou J; Liu Q; Mao T; Chen B; Wu Q; Wang L; Pathak JL; Watanabe N; Li J
Free Radic Biol Med; 2023 Aug; 205():116-128. PubMed ID: 37286044
[TBL] [Abstract][Full Text] [Related]
31. MAGE-C3 promotes cancer metastasis by inducing epithelial-mesenchymal transition and immunosuppression in esophageal squamous cell carcinoma.
Wu Q; Zhang W; Wang Y; Min Q; Zhang H; Dong D; Zhan Q
Cancer Commun (Lond); 2021 Dec; 41(12):1354-1372. PubMed ID: 34347390
[TBL] [Abstract][Full Text] [Related]
32. Proteasome inhibitors restore the STAT1 pathway and enhance the expression of MHC class I on human colon cancer cells.
Liang YH; Chen KH; Tsai JH; Cheng YM; Lee CC; Kao CH; Chan KY; Chen YT; Hsu WL; Yeh KH
J Biomed Sci; 2021 Nov; 28(1):75. PubMed ID: 34758826
[TBL] [Abstract][Full Text] [Related]
33. SOX10 Regulates Melanoma Immunogenicity through an IRF4-IRF1 Axis.
Yokoyama S; Takahashi A; Kikuchi R; Nishibu S; Lo JA; Hejna M; Moon WM; Kato S; Zhou Y; Hodi FS; Song JS; Sakurai H; Fisher DE; Hayakawa Y
Cancer Res; 2021 Dec; 81(24):6131-6141. PubMed ID: 34728538
[TBL] [Abstract][Full Text] [Related]
34. PD-L1 upregulation in myeloma cells by panobinostat in combination with interferon-γ.
Iwasa M; Harada T; Oda A; Bat-Erdene A; Teramachi J; Tenshin H; Ashtar M; Oura M; Sogabe K; Udaka K; Fujii S; Nakamura S; Miki H; Kagawa K; Ozaki S; Abe M
Oncotarget; 2019 Mar; 10(20):1903-1917. PubMed ID: 30956773
[TBL] [Abstract][Full Text] [Related]
35. Mathematical modeling for the combination treatment of IFN-γ and anti-PD-1 in cancer immunotherapy.
Liao KL; Watt KD
Math Biosci; 2022 Nov; 353():108911. PubMed ID: 36150452
[TBL] [Abstract][Full Text] [Related]
36. Interferon-γ induces tumor resistance to anti-PD-1 immunotherapy by promoting YAP phase separation.
Yu M; Peng Z; Qin M; Liu Y; Wang J; Zhang C; Lin J; Dong T; Wang L; Li S; Yang Y; Xu S; Guo W; Zhang X; Shi M; Peng H; Luo X; Zhang H; Zhang L; Li Y; Yang XP; Sun S
Mol Cell; 2021 Mar; 81(6):1216-1230.e9. PubMed ID: 33606996
[TBL] [Abstract][Full Text] [Related]
37. CAMKK2 Defines Ferroptosis Sensitivity of Melanoma Cells by Regulating AMPK‒NRF2 Pathway.
Wang S; Yi X; Wu Z; Guo S; Dai W; Wang H; Shi Q; Zeng K; Guo W; Li C
J Invest Dermatol; 2022 Jan; 142(1):189-200.e8. PubMed ID: 34242660
[TBL] [Abstract][Full Text] [Related]
38. A Novel Kinase Inhibitor AX-0085 Inhibits Interferon-γ-Mediated Induction of PD-L1 Expression and Promotes Immune Reaction to Lung Adenocarcinoma Cells.
Kim J; Jang H; Lee GJ; Hur Y; Keum J; Jo JK; Yun SE; Park SJ; Park YJ; Choi MJ; Kim KS; Kim J
Cells; 2021 Dec; 11(1):. PubMed ID: 35011581
[TBL] [Abstract][Full Text] [Related]
39. Interferon-gamma and tumor necrosis factor-alpha synergistically enhance the immunosuppressive capacity of human umbilical-cord-derived mesenchymal stem cells by increasing PD-L1 expression.
Chen Z; Yao MW; Shen ZL; Li SD; Xing W; Guo W; Li Z; Wu XF; Ao LQ; Lu WY; Lian QZ; Xu X; Ao X
World J Stem Cells; 2023 Aug; 15(8):787-806. PubMed ID: 37700823
[TBL] [Abstract][Full Text] [Related]
40. Distinct mechanisms of loss of IFN-gamma mediated HLA class I inducibility in two melanoma cell lines.
Rodríguez T; Méndez R; Del Campo A; Jiménez P; Aptsiauri N; Garrido F; Ruiz-Cabello F
BMC Cancer; 2007 Feb; 7():34. PubMed ID: 17319941
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
